Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
  • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
  • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
  • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
  • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
  • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
  • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
  • C07K16/3007—Carcino-embryonic Antigens
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
  • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
  • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
  • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
  • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
  • A61K47/6815—Enzymes
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K2317/00—Immunoglobulins specific features
  • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K2317/00—Immunoglobulins specific features
  • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
  • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
  • C07K2317/622—Single chain antibody (scFv)

Applications Claiming Priority (1)

Publications (1)

Family

ID=10838074

Family Applications (1)

Country Status (21)

Families Citing this family (7)

Family Cites Families (2)

• 1998
  • 1998-08-28 GB GBGB9818915.2A patent/GB9818915D0/en not_active Ceased
• 1999
  • 1999-08-20 PL PL99346472A patent/PL346472A1/en not_active Application Discontinuation
  • 1999-08-20 KR KR1020017002434A patent/KR20010089174A/en not_active Application Discontinuation
  • 1999-08-20 IL IL14152399A patent/IL141523A0/en unknown
  • 1999-08-20 CA CA002340865A patent/CA2340865A1/en not_active Abandoned
  • 1999-08-20 BR BR9913303-2A patent/BR9913303A/en not_active IP Right Cessation
  • 1999-08-20 AU AU54350/99A patent/AU5435099A/en not_active Abandoned
  • 1999-08-20 EA EA200100287A patent/EA200100287A1/en unknown
  • 1999-08-20 TR TR2001/00643T patent/TR200100643T2/en unknown
  • 1999-08-20 JP JP2000571062A patent/JP2002525082A/en active Pending
  • 1999-08-20 WO PCT/GB1999/002729 patent/WO2000012556A1/en not_active Application Discontinuation
  • 1999-08-20 ID IDW20010714A patent/ID28905A/en unknown
  • 1999-08-20 EP EP99940355A patent/EP1107990A1/en not_active Withdrawn
  • 1999-08-20 HU HU0103233A patent/HUP0103233A3/en unknown
  • 1999-08-20 YU YU15401A patent/YU15401A/en unknown
  • 1999-08-20 CN CN99810367A patent/CN1315966A/en active Pending
  • 1999-08-20 MX MXPA01002248A patent/MXPA01002248A/en unknown
• 2001
  • 2001-02-26 BG BG105294A patent/BG105294A/en unknown
  • 2001-02-26 ZA ZA200101573A patent/ZA200101573B/en unknown
  • 2001-02-27 NO NO20011006A patent/NO20011006D0/en not_active Application Discontinuation
  • 2001-02-28 HR HR20010149A patent/HRP20010149A2/en not_active Application Discontinuation

Also Published As

Similar Documents